News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • Pulmovant (Roivant) will present topline Phase 2 PHocus results for mosliciguat in PH-ILD at the ERS Congress on Sept 8.
  • Roivant will host an investor call immediately after the ERS presentation to discuss the topline findings.
  • Topline results will affect Pulmovant and respiratory-biotech sector valuations.
  • Star Group offers a yield above 6% and has raised distributions for 14 consecutive years.
  • Star Group generates roughly $56.8M in free cash flow with an enterprise value below $600M.
  • SGU trades at about a 5.2 P/E and ~3.2 EV/EBITDA, framing it as a reversion/value trade for income investors.

Latest Articles

Bridger Aerospace and OroraTech Advance Integration of Space-Based Data into IGNIS for Centralized Wildfire Intelligence

Bridger Aerospace and OroraTech Advance Integration of Space-Based Data into IGNIS for Centralized Wildfire Intelligence

Bridger Aerospace announced a strategic partnership with OroraTech USA to incorporate OroraTech's satellite-based wildfire detection, thermal mapping, and fire spread simulation data into Bridger's IGNIS wildfire operations platform. This integration will enhance real-time situational awareness for wildfire agencies and improve decision-making duri…

Prime Medicine to Participate in Upcoming Investor Conferences

Prime Medicine to Participate in Upcoming Investor Conferences

Prime Medicine, Inc., a biotechnology company focused on gene editing therapies, announced that its management will participate in three leading investor conferences in September 2026. The events include 1x1 meetings and fireside chats with live audio webcasts available to investors. The company highlighted its Prime Editing platform and ongoing th…

SunPower Raises $26.2 Million Cash

SunPower Raises $26.2 Million Cash

SunPower Inc. announced the successful raise of $26.2 million in a private equity placement anchored by Silicon Valley investors to support its plan to return to profitability and grow revenues from $300 million to $500 million next year. The company is recovering from a recent market setback due to loss of the Investment Tax Credit and a divisiona…

Enphase Energy Brings Smart EV Charging to More Homes Across Europe

Enphase Energy Brings Smart EV Charging to More Homes Across Europe

Enphase Energy has announced expanded metering compatibility for its IQ EV Charger 2 across multiple European markets, enabling smart EV charging for homes with or without existing Enphase solar or battery systems. This update allows dynamic load balancing and green charging using home metering data from various smart meters or CT-based solutions, …

Replimune to Present at the Cantor Global Healthcare Conference 2026

Replimune to Present at the Cantor Global Healthcare Conference 2026

Replimune Group, a biotechnology company specializing in oncolytic immunotherapies, announced that its management team will present at the Cantor Global Healthcare Conference on September 10, 2026. The company highlighted its first commercially approved product, TUDRIQEV, for advanced melanoma, and its proprietary RPx platform aiming to enhance can…

Nasdaq Verafin and Alloy Partner to Help Financial Institutions Mitigate Fraud Risk Across the Customer Lifecycle

Nasdaq Verafin and Alloy Partner to Help Financial Institutions Mitigate Fraud Risk Across the Customer Lifecycle

Nasdaq Verafin and Alloy have partnered to combine their fraud intelligence and AI capabilities, enabling financial institutions to better detect and prevent fraud throughout the customer lifecycle. The integration allows mutual customers to leverage Nasdaq Verafin's extensive fraud data network within Alloy's platform, improving real-time fraud al…

Nuvectis Pharma To Participate in Upcoming Investor Conferences

Nuvectis Pharma To Participate in Upcoming Investor Conferences

Nuvectis Pharma, a clinical-stage biopharmaceutical company focused on complement-related and oncology therapies, announced that senior management will present at two prominent investor conferences in September 2026. The events include a fireside chat at the Cantor Global Healthcare Conference and a presentation at the H.C. Wainwright Global Invest…

Clene to Present at Upcoming September Investor Conferences

Clene to Present at Upcoming September Investor Conferences

Clene Inc., a late clinical-stage biopharmaceutical company focused on neurodegenerative diseases, will present at the 2026 Cantor Global Healthcare Conference and the H.C. Wainwright 28th Annual Global Investment Conference in September 2026. Management will host one-on-one meetings and presentations, with webcasts available for investors.

XBP Europe Named to UK Government’s G-Cloud 15 Framework

XBP Europe Named to UK Government’s G-Cloud 15 Framework

XBP Global Holdings, Inc. announced that its European subsidiary, XBP Europe, has been approved again to sell services to the UK government through the updated G-Cloud 15 Framework. This renewed approval strengthens XBP's foothold in UK public sector cloud technology, offering longer contract terms and stricter security requirements, positioning th…

CURRENC Capital and Mint Incorporation Limited (NASDAQ: MIMI) Announce Collaboration to Bring Mint’s Nasdaq-Listed Shares Onchain

CURRENC Capital and Mint Incorporation Limited (NASDAQ: MIMI) Announce Collaboration to Bring Mint’s Nasdaq-Listed Shares Onchain

Mint Incorporation Limited (NASDAQ: MIMI), a company specializing in AI and robotics, announced a collaboration with CURRENC Capital to tokenize a portion of its Nasdaq-listed Class A ordinary shares on Ethereum and Solana blockchains. This issuer-sponsored tokenization aims to modernize equity ownership by enabling 24/7 global investor access, fas…

Biomea Fusion to Participate in Upcoming Investor Conferences

Biomea Fusion to Participate in Upcoming Investor Conferences

Biomea Fusion, a clinical-stage biopharmaceutical company focused on diabetes and obesity therapies, announced its participation in upcoming investor events in New York City during September 2026, including the Citi Biopharma Back to School and H.C. Wainwright Global Investment Conferences. The company will present updates on its oral small molecul…

Ovid Therapeutics to Participate in Upcoming Investor Conferences

Ovid Therapeutics to Participate in Upcoming Investor Conferences

Ovid Therapeutics announced participation of its management team in the Cantor Global Healthcare Conference and the C. Wainwright 28th Annual Global Investment Conference in September 2026. The company provided webcast access details and highlighted its focus on developing novel small molecule medicines for neurological and neuropsychiatric disorde…

General Fusion to Participate in Upcoming Investor Conferences

General Fusion to Participate in Upcoming Investor Conferences

General Fusion Group Ltd., a Nasdaq-listed company pioneering Magnetized Target Fusion technology, announced that its leadership team will attend several major investor conferences in September and October 2026. The company aims to advance its LM26 fusion demonstration machine and commercialize cost-effective, carbon-free fusion energy by the mid-2…

Positioning for the Next Bitcoin Leg Higher: An IBIT Trade Plan

Positioning for the Next Bitcoin Leg Higher: An IBIT Trade Plan

IBIT looks set to lead the next leg of Bitcoin's bull market. Technical momentum, heavy ETF inflows, and renewed institutional adoption create a favorable setup. This trade idea lays out a concrete entry at $44.34, a stop at $36.00, and a target at $80.00 with a long-term horizon (180 trading days). Risk is real — if flows reverse or macro liquidit…